Financial Ratios

CHEMCEL BIOTECH LTD.

NSE : NABSE : 533026ISIN CODE : INE213J01012Industry : Pesticides & AgrochemicalsHouse : Private
BSE0.950 (0 %)
PREV CLOSE ( ) 0.95
OPEN PRICE ( ) 0.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.95 (117664)
VOLUME 16090
TODAY'S LOW / HIGH ( )0.95 0.95
52 WK LOW / HIGH ( ) 0.950.95
NSE
This Company is not listed in NSE
Select year
ParticularsMar2011Mar2010Mar2009Mar2008Mar2007
Operational & Financial Ratios
   Earnings Per Share (Rs)0.310.530.511.200.89
   CEPS(Rs)0.340.560.541.301.01
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)15.2915.2614.5712.6411.46
   Tax Rate(%)24.5023.1925.0523.5635.83
Margin Ratios
   Core EBITDA Margin(%)4.846.278.5011.829.32
   EBIT Margin(%)4.696.088.2311.388.82
   Pre Tax Margin(%)2.253.824.896.726.25
   PAT Margin (%)1.702.943.665.134.01
   Cash Profit Margin (%)1.863.133.935.574.55
Performance Ratios
   ROA(%)1.502.663.484.744.22
   ROE(%)2.113.555.149.959.78
   ROCE(%)4.656.189.3514.4213.65
   Asset Turnover(x)0.880.910.950.921.05
   Sales/Fixed Asset(x)21.9720.1715.6213.9718.91
   Working Capital/Sales(x)1.131.151.051.291.34
Efficiency Ratios
   Fixed Capital/Sales(x)0.050.050.060.070.05
   Receivable days202.67187.79178.73162.53134.73
   Inventory Days37.0232.2823.8119.7419.44
   Payable days18.8720.1929.390.00-6879.44
Valuation Parameters
   PER(x)16.1815.8812.460.000.00
   PCE(x)14.8414.9111.610.000.00
   Price/Book(x)0.330.550.430.000.00
   Yield(%)0.000.000.00
   EV/Net Sales(x)0.480.680.610.710.73
   EV/Core EBITDA(x)9.7610.697.005.997.76
   EV/EBIT(x)10.0811.037.236.228.23
   EV/CE(x)0.400.560.450.610.68
   M Cap / Sales0.280.480.460.000.00
Growth Ratio
   Net Sales Growth(%)9.6130.0643.175.329.20
   Core EBITDA Growth(%)-15.67-3.854.8633.0451.16
   EBIT Growth(%)-15.79-3.765.5135.8656.43
   PAT Growth(%)-36.714.424.0834.7623.71
   EPS Growth(%)-41.254.43-57.7634.76-21.80
Financial Stability Ratios
   Total Debt/Equity(x)0.240.240.130.530.53
   Current Ratio(x)9.078.0912.263.383.73
   Quick Ratio(x)8.117.2311.163.213.52
   Interest Cover(x)1.922.692.462.443.43
   Total Debt/Mcap(x)0.720.440.31

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.